Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Count down for Ryplazim FDA Decision

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Apr 05, 2021 11:31am

71 Views

Post# 32937183

RE:Count down for Ryplazim FDA Decision

StockReddy, why do you feel that Liminal announced that they are selling or shutting down the division in late January? Is this a positive sign for you? If so, why? I took it as a negative that they would actually say that closing down division is a possibility.